NR4A3 and hepatocellular carcinoma: Given that NR4A3 increased CDKN2AIP expression in HCC cells, we analyzed the expression of NR4A3 and CDKN2AIP in HCC and matched adjacent noncancerous liver tissues in TCGA dataset and the HCC patients we collected.